These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 5404870

  • 1. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA, de Bulhões F, Tuma M.
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N.
    Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of arteriosclerosis by Atromid].
    Ayad H.
    Rev Med Moyen Orient; 1967 Mar 03; 24(6):504-11. PubMed ID: 5264185
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)].
    Yasugi T, Sasa E.
    Nihon Rinsho; 1970 May 03; 28(5):1470-4. PubMed ID: 4915308
    [No Abstract] [Full Text] [Related]

  • 9. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
    Albert M, Stansell MJ.
    Metabolism; 1969 Aug 03; 18(8):635-45. PubMed ID: 4895062
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S, Nizzola GM.
    Ann Ottalmol Clin Ocul; 1970 Sep 03; 96(9):477-82. PubMed ID: 5519038
    [No Abstract] [Full Text] [Related]

  • 13. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M, Sekimoto H, Nakada I, Takegoshi T, Iwaki N.
    Naika; 1970 Jun 03; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical and therapeutic evaluation of simfibrate compared toclofibrate in atherosclerotic patients].
    De Rosa G, Savi L, De Rosa E, Pola P, Boni P.
    Clin Ter; 1979 Feb 15; 88(3):267-79. PubMed ID: 376218
    [No Abstract] [Full Text] [Related]

  • 15. Long-term monitoring during clofibrate therapy.
    Vester JW, Sunder JH, Aarons JH, Danowski TS.
    Clin Pharmacol Ther; 1970 Feb 15; 11(5):689-97. PubMed ID: 5460240
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971 Feb 15; 23():101-3. PubMed ID: 5562226
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL, Desbois JC, Marie J.
    Ann Pediatr (Paris); 1970 Nov 02; 17(11):754-9. PubMed ID: 5484620
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.